Help Shape the Future of Pharmacogenetic Policy in Canada
Summary
Researchers at the University of Calgary are studying how pharmacogenetic (PGx) testing policies are being developed and used in Canada to support mental health care for children and young people.
Eligibility
Eligible ages: 18 to 60
Accepts healthy participants: Yes
Inclusion criteria:
Who can participate?
Individuals who work in:
• Health-policy development or government roles
• Clinical leadership or service delivery
• Genomics or pharmacogenetics research
• Ethics, legal, or health-equity organizations
• Community or patient-advocacy groups
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Interested? Contact: Prosper Mandela Awuni | University of Calgary
Principal investigator:
Jennifer Zwicker
Clinical trial:
No
REB-ID:
REB25-1786